Drug Shortage Report for LACTULOSE SOLUTION USP

Last updated on 2017-07-31 History
Report ID 360
Drug Identification Number 02242814
Brand name APO-LACTULOSE
Common or Proper name LACTULOSE
Company Name BAJAJ MEDICAL, LLC
Market Status DORMANT
Active Ingredient(s) LACTULOSE
Strength(s) 667MG
Dosage form(s) LIQUID
Route of administration ORAL
Packaging size 500 ml
ATC code A06AD
ATC description DRUGS FOR CONSTIPATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-10
Estimated end date 2017-08-08
Actual end date 2017-07-31
Shortage status Resolved
Updated date 2017-07-31
Company comments Supply will be unstabe going forward
Health Canada comments
Tier 3 Status No
Contact Address 415 W PERSHING RD
CHICAGO, ILLINOIS
UNITED STATES 60609
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2017-07-31 French Compare
v17 2017-07-31 English Compare
v16 2017-07-17 French Compare
v15 2017-07-17 English Compare
v14 2017-05-25 French Compare
v13 2017-05-25 English Compare
v12 2017-05-25 French Compare
v11 2017-05-25 English Compare
v10 2017-05-16 French Compare
v9 2017-05-16 English Compare
v8 2017-05-10 French Compare
v7 2017-05-10 English Compare
v6 2017-04-24 French Compare
v5 2017-04-24 English Compare
v4 2017-04-04 French Compare
v3 2017-04-04 English Compare
v2 2017-03-10 French Compare
v1 2017-03-10 English Compare

Showing 1 to 18 of 18